FinTechFunding

Immutep: Partners with LabCorp

  • Immutep (IMM) has entered a license and collaboration agreement with Laboratory Corporation of American Holdings (LabCorp)
  • The companies will also collaborate to develop immuno-oncology products and services
  • LabCorp is a North Carolina-based clinical lab company that operates one of the largest clinical laboratory networks in the world
  • The collaboration also allows Immutep to enter the immuno-oncology diagnostics field
  • Immutep is developing LAG-3-related immunotherapeutic products to treat cancer and autoimmune disease
  • Company shares ended the day trading up a slight 1.96 percent for 26 cents
Previous article
Pleo: Tackles expense management with Pocket
Next article
Stablehouse: Announced Seed funding of $2.18 million
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

DeFi Platform Drift Suspends Withdrawals After Crypto Hack

Drift takes precautionary measures following security breach affecting user funds.Highlights: Drift has suspended all deposits and withdrawals after...
FinTech

Cross River Bank Raises $50 Million to Accelerate Growth

The funding will enhance Cross River Bank's financial technology services.Highlights: Cross River Bank has raised $50 million in...
FinTech

Kulipa Secures $62M to Enhance Stablecoin Card Issuing Infrastructure

Funding aims to strengthen cryptocurrency card services in the growing fintech market.Highlights: Kulipa raises $62M to enhance its...
FinTech

Visa Launches AI-Powered Dispute Resolution Tools

New tools aim to streamline resolution of payment disputes.Highlights: Visa introduces AI tools for payment dispute resolution.The new...